
About Jenfer Biosciences
Jenfer Biosciences is a Healthcare company based in Ambala (India) founded in 2015. Manufacturing and supplying pharmaceutical formulations, including tablets and injections, with a focus on Pharma Franchise in India. Its Indian entity Jenfer Biosciences Private Limited reported revenue of βΉ96.2 Lakh. Jenfer Biosciences offers products and services including Tablets and Injections. Its focus areas include Distribution, Pharma Franchise, Distribution Rights and Pharmaceuticals.
Company details
Jenfer Biosciences is engaged in the manufacturing and supplying of a wide range of pharmaceutical formulations, such as tablets, injections, and capsules, which are DCGI approved and produced under ISO 9001:2000 and GMP WHO norms. The company provides Pharma Franchise and PCD rights across India, emphasizing quality assurance and timely delivery to ensure customer satisfaction. Products are analyzed for quality before distribution, supporting health improvement and disease treatment. A commitment to excellence is maintained through diverse team efforts and ethical standards.
- Headquarters Ambala, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website jenferbio.com
- Legal Name Jenfer Biosciences Private Limited
- Date of Incorporation 26 May, 2015
- Jurisdiction Ambala Cantt, Haryana, India
- Annual Revenue₹96.2 Lakh
FY 2026 · -14% YoY
- Net Profit₹15,642
FY 2026 · 0% margin
- EBITDA₹86,100
FY 2026 · 1% margin
Associated legal entities of Jenfer Biosciences
Jenfer Biosciences operates through Jenfer Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jenfer Biosciences Private Limited CIN U51909HR2015PTC055567 | Active | 26 May 2015 | Ambala Cantt, Haryana | ₹1.0 Cr | 4 | View details |
Products & Services of Jenfer Biosciences
Jenfer Biosciences offers a comprehensive portfolio of products and services, including Tablets and Injections.
Tablets are manufactured and supplied for various therapeutic uses, including analgesics and antibiotics
Injections are produced and supplied as DCGI-approved formulations for medical treatments
Board of directors of Jenfer Biosciences Private Limited (Jenfer Biosciences)
Jenfer Biosciences Private Limited is the primary company behind Jenfer Biosciences. The board of Jenfer Biosciences Private Limited currently have 4 directors; the longest-serving is Jitendra Mohan Roy, appointed in 2015.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jitendra Mohan Roy DIN 02745087 | Director | 26 May 2015 | 11 yrs 5 mo | Jenfer Biosciences Private Limited |
| Sunita DIN 06956116 | Director | 26 May 2015 | 11 yrs 5 mo | Jenfer Biosciences Private Limited |
| Munish Aggarwal DIN 07181798 | Director | 26 May 2015 | 11 yrs 5 mo | Jenfer Biosciences Private Limited |
| Varesh Khanna DIN 05142658 | Director | 26 May 2015 | 11 yrs 5 mo | Jenfer Biosciences Private Limited |
Financials of Jenfer Biosciences
Figures of Jenfer Biosciences Private Limited, the primary company behind Jenfer Biosciences, for FY 2026. Revenue was ₹96.2 Lakh (-14% year on year). Net profit was ₹15,642 (0% margin). EBITDA was ₹86,100 (1% margin). Revenue has grown at a compounded annual rate of -13% over three years and -7% over five years.
- ₹96.2 LakhRevenue · FY 2026 · -14% YoY
- ₹15,642Net profit · 0% margin
- ₹86,100EBITDA · 1% margin
- ₹1 LakhPaid-up capital
- -13%Revenue CAGR, 3 years
- -7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Jenfer Biosciences Private Limited are on its company page.
Detailed financial statements for Jenfer Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jenfer Biosciences
Jenfer Biosciences was founded in 2015.
Jenfer Biosciences is headquartered in Ambala, India. It is registered at Ambala, Haryana, India.
The primary company behind Jenfer Biosciences, Jenfer Biosciences Private Limited, reported revenue of βΉ96.2 Lakh for FY 2026, down 14% year on year.
Jenfer Biosciences is engaged in the manufacturing and supplying of a wide range of pharmaceutical formulations, such as tablets, injections, and capsules, which are DCGI approved and produced under ISO 9001:2000 and GMP WHO norms. The company provides Pharma Franchise and PCD rights across India, emphasizing quality assurance and timely delivery to ensure customer satisfaction. Products are analyzed for quality before distribution, supporting health improvement and disease treatment. A commitment to excellence is maintained through diverse team efforts and ethical standards.
Jenfer Biosciences offers Tablets and Injections.
Jenfer Biosciences operates through Jenfer Biosciences Private Limited.
The legal entities of Jenfer Biosciences currently have 4 directors, including Jitendra Mohan Roy, Sunita, Munish Aggarwal and others.